Promoting tumor angiogenesis, tumor immune escape, and loss of activity to kill tumor stem cells have been demonstrated to be involved in promoting the malignant progression of CD56(bright) NK cells [33, 38, 39]. This evidence concerns the gene NCAM1 and neoplasm.